Notch signalling in primary cutaneous CD30+ lymphoproliferative disorders: a new therapeutic approach?

Research output: Contribution to journalJournal articleResearchpeer-review

The oncogenic potential of deregulated Notch signalling has been described in several haematopoietic malignancies. We have previously reported an increased expression of Notch1 in primary cutaneous CD30+ lymphoproliferative disorders, lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma (pcALCL).
Original languageEnglish
JournalBritish Journal of Dermatology
Issue number4
Pages (from-to)781-8
Number of pages8
Publication statusPublished - 1 Oct 2010

ID: 34126059